130 related articles for article (PubMed ID: 8723192)
1. High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation.
Kliem V; Thon W; Krautzig S; Kolditz M; Behrend M; Pichlmayr R; Koch KM; Frei U; Brunkhorst R
Transpl Int; 1996; 9(3):231-5. PubMed ID: 8723192
[TBL] [Abstract][Full Text] [Related]
2. Denovo urothelial carcinoma of the upper and lower urinary tract in kidney--transplant patients with end-stage analgesic nephropathy.
Thon WF; Kliem V; Truss MC; Anton P; Kuczyk M; Stief CG; Brunkhorst R
World J Urol; 1995; 13(4):254-61. PubMed ID: 8528303
[TBL] [Abstract][Full Text] [Related]
3. Risk of renal cell carcinoma after kidney transplantation.
Kliem V; Kolditz M; Behrend M; Ehlerding G; Pichlmayr R; Koch KM; Brunkhorst R
Clin Transplant; 1997 Aug; 11(4):255-8. PubMed ID: 9267711
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic nephroureterectomy to exclude upper urinary tract malignancy associated with analgesic nephropathy.
Doehn C; Fornara P; Fricke L; Jocham D
J Endourol; 2001 Oct; 15(8):809-14. PubMed ID: 11724120
[TBL] [Abstract][Full Text] [Related]
5. The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure.
McCredie M; Stewart JH; Mathew TH; Disney AP; Ford JM
Clin Nephrol; 1989 Jan; 31(1):35-9. PubMed ID: 2783667
[TBL] [Abstract][Full Text] [Related]
6. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.
Lemy A; Wissing KM; Rorive S; Zlotta A; Roumeguere T; Muniz Martinez MC; Decaestecker C; Salmon I; Abramowicz D; Vanherweghem JL; Nortier J
Am J Kidney Dis; 2008 Mar; 51(3):471-7. PubMed ID: 18295063
[TBL] [Abstract][Full Text] [Related]
7. Incidence of analgesic nephropathy in Berlin since 1983.
Schwarz A; Preuschof L; Zellner D
Nephrol Dial Transplant; 1999 Jan; 14(1):109-12. PubMed ID: 10052487
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis.
Végsö G; Toronyi E; Hajdu M; Piros L; Görög D; Deák PA; Doros A; Péter A; Langer RM
Transplant Proc; 2011 May; 43(4):1261-3. PubMed ID: 21620106
[TBL] [Abstract][Full Text] [Related]
9. Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract.
Gonwa TA; Corbett WT; Schey HM; Buckalew VM
Ann Intern Med; 1980 Aug; 93(2):249-52. PubMed ID: 7406375
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
11. Urine cytology as a screening method for transitional-cell carcinoma in dialysis patients with analgesic nephropathy.
Veltman GA; Bosch FH; van der Plas-Cats MB; van Leusen R
Nephrol Dial Transplant; 1991; 6(5):346-8. PubMed ID: 1870751
[TBL] [Abstract][Full Text] [Related]
12. Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy.
Blohmé I; Johansson S
Kidney Int; 1981 Nov; 20(5):671-5. PubMed ID: 7045494
[TBL] [Abstract][Full Text] [Related]
13. Analgesic nephropathy as a cause of end-stage renal disease in a 55 year-old Nigerian.
Okafor UH; Unuigbe EI; Onwuchekwa AC; Emem-Chioma P
Niger J Clin Pract; 2012; 15(2):231-4. PubMed ID: 22718180
[TBL] [Abstract][Full Text] [Related]
14. Analgesic nephropathy and renal transplantation.
Schwarz A; Offermann G; Keller F
Nephrol Dial Transplant; 1992; 7(5):427-32. PubMed ID: 1321379
[TBL] [Abstract][Full Text] [Related]
15. Morbidity of patients with analgesic-associated nephropathy on regular dialysis treatment and after renal transplantation.
Ballé C; Schollmeyer P
Klin Wochenschr; 1990 Jan; 68(1):38-42. PubMed ID: 2106598
[TBL] [Abstract][Full Text] [Related]
16. Obituary to analgesic nephropathy--an autopsy study.
Mihatsch MJ; Khanlari B; Brunner FP
Nephrol Dial Transplant; 2006 Nov; 21(11):3139-45. PubMed ID: 16891638
[TBL] [Abstract][Full Text] [Related]
17. De novo urothelial carcinoma in kidney transplantation patients with end-stage aristolochic acid nephropathy in China.
Li HZ; Xia M; Han Y; Xu XG; Zhang YS
Urol Int; 2009; 83(2):200-5. PubMed ID: 19752617
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma in peritoneal dialysis patients.
Savaj S; Liakopoulos V; Ghareeb S; Musso C; Sahu K; Bargman JM; Vas SI; Oreopoulos DG
Int Urol Nephrol; 2003; 35(2):263-5. PubMed ID: 15072507
[TBL] [Abstract][Full Text] [Related]
19. Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.
Michielsen P; Heinemann L; Mihatsch M; Schnülle P; Graf H; Koch KM
Nephrol Dial Transplant; 2009 Apr; 24(4):1253-9. PubMed ID: 19037086
[TBL] [Abstract][Full Text] [Related]
20. Concurrent urothelial carcinoma in the renal pelvis of an allograft kidney and native recipient bladder: evidence of donor origin.
Takaoka E; Miyazaki J; Kimura T; Kojima T; Kawai K; Murata Y; Itoguchi N; Minami Y; Nakamura T; Honda K; Nishiyama H
Jpn J Clin Oncol; 2014 Apr; 44(4):366-9. PubMed ID: 24596334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
